首页 | 本学科首页   官方微博 | 高级检索  
     


Immuno-oncology for Hepatocellular Carcinoma: The Present and the Future
Affiliation:1. Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, 1120 Northwest 14th Street, Office 1189, Miami, FL 33136, USA;2. Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, 1120 Northwest 14th #1115, Miami, FL 33136, USA;1. Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 303 Brookline Avenue, Boston, MA 02215, USA;2. Department of Pathology, Yale School of Medicine, 310 Cedar Street, PO Box 208023, New Haven, CT 06520-8023, USA;1. Anesthesia Department, Hospital Clinic of Barcelona, Villarroel 170, Barcelona 08036, Spain;2. Institut d’Investigacions Biomèdiques August Pi-Sunyer (IDIBAPS) and Ciber de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain;3. GI/Liver Unit, Institut Clínic de Malalties Digestives i Metabòliques, Hospital Clínic, Barcelona, Spain;4. Department of Medicine, University of Barcelona, Spain
Abstract:
Keywords:Hepatocellular carcinoma  Immunotherapy  Checkpoint inhibitor
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号